Security key
007002108
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001
- Total 13F shares
- 57,616,208
- Total 13F value
- $55,430,722
- Share change
- -553,061
- Put/Call ratio
- 538%
- SEC-reported price per share
- $0.96
- Number of holders
- 61
- Value change
- -$613,083
- Number of buys
- 18
- Number of sells
- 29
- Shares outstanding
- 9,599,852
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
61
Top holders
10
ACET full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Adicet Bio, Inc. SEC filings
Adicet Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 007002108
Recent filing periods:
Ownership snapshot
Top reported holders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Carl L. Gordon
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5
13F
Highest disclosed value: $16,483,882
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC has the largest disclosed position value at $16.48M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
Carl L. Gordon
$941.6K
ORBIMED ADVISORS LLC
$16.48M
TANG CAPITAL MANAGEMENT LLC
$11.83M
RA CAPITAL MANAGEMENT, L.P.
$10.86M
GOLDMAN SACHS GROUP INC
$5.41M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Carl L. Gordon |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$941,594
684,857 shares
mixed-class rows
|
— | 21 Aug 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$16,483,882
11,447,140 shares
|
— | 30 Sep 2024 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$11,832,422
8,216,960 shares
|
— | 30 Sep 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
—
denominator unverified
|
$10,859,040
7,541,000 shares
|
— | 30 Sep 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
denominator unverified
|
$5,414,396
3,759,997 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$4,616,470
3,205,882 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
61
Shares
57,616,208
Rows available
61
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q1 2026 Across Filers
Q1 2026 holders
1
Q4 2024 holders
61
Holder diff
60
| Investor | Q1 2026 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend